Cargando…

IRAK4 is essential for TLR9-induced suppression of Epstein-Barr virus BZLF1 transcription in Akata Burkitt’s lymphoma cells

Burkitt’s lymphoma (BL) is the most common childhood cancer in equatorial Africa, and is endemic to areas where people are chronically co-infected with Epstein-Barr virus (EBV) and the malaria pathogen Plasmodium falciparum. The contribution of these pathogens in the oncogenic process remains poorly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jordi, Marc, Marty, Jeannine, Mordasini, Vanessa, Lünemann, Anna, McComb, Scott, Bernasconi, Michele, Nadal, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663394/ https://www.ncbi.nlm.nih.gov/pubmed/29088270 http://dx.doi.org/10.1371/journal.pone.0186614

Ejemplares similares

Zebularine reactivates silenced E-cadherin but unlike 5-Azacytidine does not induce switching from latent to lytic Epstein-Barr virus infection in Burkitt's lymphoma Akata cells
por: Rao, Sieta P, et al.
Publicado: (2007)

MCAF1 and Rta-Activated BZLF1 Transcription in Epstein-Barr Virus
por: Lin, Ting-Yu, et al.
Publicado: (2014)

Urea-Mediated Cross-Presentation of Soluble Epstein-Barr Virus BZLF1 Protein
por: Barabas, Sascha, et al.
Publicado: (2008)

Methylation-Dependent Binding of the Epstein-Barr Virus BZLF1 Protein to Viral Promoters
por: Dickerson, Sarah J., et al.
Publicado: (2009)

PARP1 restricts Epstein Barr Virus lytic reactivation by binding the BZLF1 promoter
por: Lupey-Green, Lena N., et al.
Publicado: (2017)

Epstein-Barr virus and Burkitt lymphoma
por: Rowe, Martin, et al.
Publicado: (2014)

BZLF1 Governs CpG-Methylated Chromatin of Epstein-Barr Virus Reversing Epigenetic Repression
por: Woellmer, Anne, et al.
Publicado: (2012)

Epigenetic modification of the Epstein-Barr virus BZLF1 promoter regulates viral reactivation from latency
por: Murata, Takayuki, et al.
Publicado: (2013)

A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection
por: Bristol, Jillian A., et al.
Publicado: (2018)

Regulation of Epstein-Barr Virus Life Cycle and Cell Proliferation by Histone H3K27 Methyltransferase EZH2 in Akata Cells
por: Ichikawa, Takaya, et al.
Publicado: (2018)

Quantitative profiling of housekeeping and Epstein-Barr virus gene transcription in Burkitt lymphoma cell lines using an oligonucleotide microarray
por: Bernasconi, Michele, et al.
Publicado: (2006)

Chlorpyrifos Induces the Expression of the Epstein-Barr Virus Lytic Cycle Activator BZLF-1 via Reactive Oxygen Species
por: Zhao, Ling, et al.
Publicado: (2015)

Epstein-Barr virus, malaria and endemic Burkitt lymphoma
por: Velavan, Thirumalaisamy P.
Publicado: (2018)

CD4 + T cells are found within endemic Burkitt lymphoma and modulate Burkitt lymphoma precursor cell viability and expression of pathogenically relevant Epstein–Barr virus genes
por: Sidorov, Semjon, et al.
Publicado: (2021)

Burkitt Lymphomas Evolve to Escape Dependencies on Epstein-Barr Virus
por: Hutcheson, Rebecca L., et al.
Publicado: (2021)

TLR9 agonists induced cell death in Burkitt's lymphoma cells is variable and influenced by TLR9 polymorphism
por: Noack, J, et al.
Publicado: (2012)

Structural basis of DNA methylation-dependent site selectivity of the Epstein–Barr virus lytic switch protein ZEBRA/Zta/BZLF1
por: Bernaudat, Florent, et al.
Publicado: (2021)

Burkitt's lymphoma: The Rosetta Stone deciphering Epstein-Barr virus biology
por: Rowe, Martin, et al.
Publicado: (2009)

Identification of Epstein-Barr Virus Replication Proteins in Burkitt’s Lymphoma Cells
por: Traylen, Chris, et al.
Publicado: (2015)

Simplified detection of Epstein-Barr virus for diagnosis of endemic Burkitt lymphoma
por: Gardner, Andrea, et al.
Publicado: (2022)

A Role for the Nucleosome Assembly Proteins TAF-Iβ and NAP1 in the Activation of BZLF1 Expression and Epstein-Barr Virus Reactivation
por: Mansouri, Sheila, et al.
Publicado: (2013)

1778. Epstein–Barr Virus Genetic Diversity: Evaluation of BZLF1 Variants among Bone Marrow Transplant Patients and Individuals with Infectious Mononucleosis
por: Abdulnoor, Mariana, et al.
Publicado: (2019)

Methylation profiling of Epstein-Barr virus immediate-early gene promoters, BZLF1 and BRLF1 in tumors of epithelial, NK- and B-cell origins
por: Li, Lili, et al.
Publicado: (2012)

The B-Cell Specific Transcription Factor, Oct-2, Promotes Epstein-Barr Virus Latency by Inhibiting the Viral Immediate-Early Protein, BZLF1
por: Robinson, Amanda R., et al.
Publicado: (2012)

Analysis of an ankyrin-like region in Epstein Barr Virus encoded (EBV) BZLF-1 (ZEBRA) protein: implications for interactions with NF-κB and p53
por: Dreyfus, David H, et al.
Publicado: (2011)

Changes in SUMO-modified proteins in Epstein-Barr virus infection identifies reciprocal regulation of TRIM24/28/33 complexes and the lytic switch BZLF1
por: De La Cruz-Herrera, Carlos F., et al.
Publicado: (2023)

Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus
por: Navari, Mohsen, et al.
Publicado: (2014)

Parthenolide induces apoptosis and lytic cytotoxicity in Epstein-Barr virus-positive Burkitt lymphoma
por: LI, YUAN, et al.
Publicado: (2012)

Epstein–Barr virus positivity as a defining pathogenetic feature of Burkitt lymphoma subtypes
por: Leoncini, Lorenzo
Publicado: (2021)

Epstein-Barr Virus Evades CD4(+) T Cell Responses in Lytic Cycle through BZLF1-mediated Downregulation of CD74 and the Cooperation of vBcl-2
por: Zuo, Jianmin, et al.
Publicado: (2011)

Microgeographic variations in Burkitt's lymphoma incidence correlate with differences in malnutrition, malaria and Epstein–Barr virus
por: Sumba, P O, et al.
Publicado: (2010)

How does Epstein–Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma?
por: Allday, Martin J.
Publicado: (2009)

The presence of Epstein-Barr virus significantly impacts the transcriptional profile in immunodeficiency-associated Burkitt lymphoma
por: Navari, Mohsen, et al.
Publicado: (2015)

Human and Epstein-Barr Virus miRNA Profiling as Predictive Biomarkers for Endemic Burkitt Lymphoma
por: Oduor, Cliff I., et al.
Publicado: (2017)

Worldwide Prevalence of Epstein–Barr Virus in Patients with Burkitt Lymphoma: A Systematic Review and Meta-Analysis
por: Al-Khreisat, Mutaz Jamal, et al.
Publicado: (2023)

Burkitt's lymphoma: differential killing of Epstein-Barr virus (EBV) (+) and EBV(-) Burkitt lymphoma cells in vitro and dose-dependent lytic induction by bortezomib in vivo
por: Dufresne, AL, et al.
Publicado: (2009)

Telomerase Activity Impacts on Epstein-Barr Virus Infection of AGS Cells
por: Rac, Jürgen, et al.
Publicado: (2015)

Tonsillar CD56brightNKG2A+ NK cells restrict primary Epstein-Barr virus infection in B cells via IFN-γ
por: Jud, Aurelia, et al.
Publicado: (2016)

Relationship of Epstein-Barr Virus and Interleukin 10 Promoter Polymorphisms with the Risk and Clinical Outcome of Childhood Burkitt Lymphoma
por: Minnicelli, Carolina, et al.
Publicado: (2012)

Primary Burkitt’s lymphoma of the thyroid without Epstein-Barr virus infection: A case report and literature review
por: ZHANG, LIYING, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_k2f97aucfhtqnkhn335pu567ra